See Article by Ghelani et al F unctionally univentricular congenital heart disease, in which only 1 ventricle is fully developed, is fatal without treatment. It has an incidence of 0.08 to 0.4 per 1000 births. 1 In patients with these types of congenital heart disease, the current treatment strategy (the Fontan operation) has reduced the mortality to the point where a large number of patients survive into adulthood. Using the Fontan strategy, the single ventricle provides the energy needed to provide blood flow through the systemic and the pulmonary vascular bed and is subjected to increased afterload. Other characteristics of the highly abnormal Fontan circulation include increased central venous pressures, a loss of pulsatility in the pulmonary arteries, and preload insufficiency of the single ventricle. Currently, early surgical mortality is ±1%.
ventricular valve insufficiency had larger ventricles. They also had worse GCS and higher global average midwall end-systolic wall fiber stress (ESFSga). There was a significant linear decline in GCS with increased ESFSga.
In a subgroup of 81 patients, 28 with single RV, cardiopulmonary exercise testing data were available. It is unclear how many of these patients had atrioventricular valve regurgitation, which hampers comparison. A statistically significant but only fair correlation was observed between predicted peak oxygen uptake and ejection fraction, not with ESFSga or GCS.
With 20 patients meeting the composite end point, few predictor variables for the end point could be tested. In univariate analysis, end-diastolic volume index and GCS were associated with death or the need for heart transplant.
The message from this study is that even in relatively young Fontan patients, there is a substantial risk for early death or circulatory failure. 7 This seems to be more prevalent in those with single ventricles of RV morphology. Of the CMR imaging parameters used to study single ventricular characteristics, it has been demonstrated by the same group from Boston children's hospital that enlarged single ventricular size is a risk factor for early death or transplantation. 8 The role of ventricular strain in risk assessment has also been demonstrated before. 9 The new information in this article relates to the assessment of wall stress and fiber stress. ESFSga had a negative correlation with ejection fraction. Patients with larger sizes of their single ventricles in conjunction with more atrioventricular valve regurgitation have worse GCS and higher ESFSga. There was a significant decline in GCS with increased ESFSga. The RV subgroup had lower mass-to-volume ratio than the LV subgroup. 7 The RV in subpulmonary position is well known to have a complex geometric shape. Although the RV in subaortic position assumes a more globular shape and it therefore seems fair to approach this ventricle as such, it should be taken into account that the methods used by Ghelani et al for assessment of end systolic wall stress and ESFSga have not been validated for other geometric shapes than a sphere or a cylinder. 10, 11 The article does not provide details of the shape of the ventricles in either group. These factors reduce the ability to directly compare the results of single RV and LV and may render the results less accurate. Nevertheless, the data clearly show that ventricular volumes were higher and mass-tovolume ratio was lower for single RV, which would suggest higher wall stress. This was confirmed by the results of end systolic wall stress and ESFSga, despite lower blood pressure in the single RV patients. Interpretation of the data is hampered by the differences in the severity of atrioventricular valve regurgitation between RV and LV group. It might be argued, as the authors seem to have done, that atrioventricular valve insufficiency is an intrinsic part of RV dysfunction. 12 There is sufficient data to support this position. However, if the aim of the article was to assess the impact of single ventricular morphology on stress and strain, matching of groups for the amount of atrioventricular valve regurgitation might have been preferred. In its current form, the article tells us that in single RVs with at least moderate of atrioventricular valve insufficiency, the ventricle dilates, which cannot be matched adequately by an increase in wall mass. This causes inappropriately increased wall stress with concomitant decline of contractile function. In comparison, single LVs with less atrioventricular valve insufficiency are less dilated, have lower wall stress, and have better ejection fraction and GCS. The findings of this study are important because they stress the relevance of and available options for careful and detailed monitoring of patients with single ventricles. For these ventricles, as for the LV and RV in the biventricular circulation, increases in load not matched by appropriate increase in wall mass result in increased wall stress, which may be detrimental for ventricular function. It has been long known that in the intermediate situation between adaptation of a ventricle to abnormal loading conditions and the ultimate development of ventricular failure "… the task of the clinician is to identify this intermediate stage and to correct the abnormal hemodynamic loading before the transition to pathologic hypertrophy becomes complete". 13 Studies on prediction of adverse events in patients with a Fontan circulation have identified several other postoperative risk factors than studied in the current article, including elevated central venous pressure and lower arterial saturation, peak heart rate and peak oxygen uptake during cardiopulmonary exercise testing, serum levels of sodium, creatinine, and brain natriuretic peptide. [14] [15] [16] This means that for this high-risk population, we have several means to identify in an early stage those at risk, and work is ongoing on additional factors, such as tissue characterization, serum biomarkers, stress imaging, or ventriculo-arterial coupling. [17] [18] [19] [20] It remains a major challenge how to use these data to modify the course of the disease in Fontan patients. Treatment of arrhythmias or residual problems amenable to surgery or catheter intervention is widely available. However, in many patients, the problem is with intrinsic abnormalities of the Fontan circulation. Theoretical concepts dictate, we should decrease afterload and alter unfavorable situations of ventricular-arterial coupling, improve venous return to the pulmonary arteries, decrease energy loss in Fontan baffles, decrease pulmonary vascular resistance, and improve inflow impairment, diastolic limitations, and energy efficiency of the ventricles. New surgical concepts, pulmonary vasodilator and lusitropic drugs, mechanical support, exercise and strength training, and other innovative therapies, taking into account basic cardiac physiology,
